Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure
- 14 April 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 86 (7) , E80-4
- https://doi.org/10.1161/01.res.86.7.e80
Abstract
—Maintenance of cardiac performance is tightly controlled by the autonomic nervous system. In congestive heart failure (CHF), although the adverse pathophysiological effects of cardiac symp...Keywords
This publication has 29 references indexed in Scilit:
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogsNeurochemistry International, 1992
- Nerve growth factor synthesis in vascular smooth muscle.Hypertension, 1991
- Induction of Nerve Growth Factor Gene Expression by 12‐O‐Tetradecanoyl Phorbol 13‐AcetateJournal of Neurochemistry, 1990
- Phorbol 12‐myristate 13‐acetate (PMA) increases the expression of the nerve growth factor (NGF) gene in mouse L‐929 fibroblastsFEBS Letters, 1990
- Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cellsFEBS Letters, 1989
- Developmental changes of nerve growth factor levels in sympathetic ganglia and their target organsDevelopmental Biology, 1988
- Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cellsBiochemical and Biophysical Research Communications, 1987
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984